StockData
Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc. (NAUT) stock

NAUTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 6/30
$2.12−0.05 (-2.30%)

Close on Nov 20, 2026Market cap $270.03MP/E –Yield –

Nautilus Biotechnology operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2021Mar 31, 2021-$1.78M–
Q3 FY2020Sep 30, 2020-$174.67K–

More Nautilus Biotechnology figures

See a number that looks wrong?